Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN (Generic Health Pty Ltd)
Product name
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
147 (255 working days)
Active ingredients
sildenafil citrate
Registration type
New generic medicine
Indication
SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN (film-coated tablet) is indicated for the treatment of erectile dysfunction in adult males. SILDENAFIL GH; SILDENAFIL LAPL; SILDENAFIL LUPIN is not indicated for use by women.